key: cord-0313739-kw07gfds authors: Hossain, M. A.; Hossain, K. M. A.; Saunders, K.; Uddin, Z.; Walton, L. M.; Raigangar, V.; Sakel, M.; Shafin, R.; Hossain, M. S.; Kabir, M. F.; Faruqui, R.; Rana, S.; Ahmed, M. S.; Chakrovorty, S. K.; Jahid, I. K. title: Prevalence of Long COVID symptoms in Bangladesh: A Prospective Inception Cohort Study of COVID-19 survivors. date: 2021-07-06 journal: nan DOI: 10.1101/2021.07.03.21259626 sha: 2b12f38d0fbae6e68523b1df4e20fb185c6a0bbf doc_id: 313739 cord_uid: kw07gfds Background: The aim of this study was to identify the prevalence of 'Long COVID' symptoms (LCS) in a large cohort of survivors and identify any potential associated risk factors. Methods: A prospective survey was undertaken of an inception cohort of confirmed COVID-19 survivors (Aged 18 to 87 years). 14392 participants were recruited from 24 testing facilities across Bangladesh between June, and November 2020. All participants had a previously confirmed positive COVID-19 diagnosis, and reported persistent symptoms and difficulties in performing daily activities. Participants who consented, were contacted by telephone, and were interviewed regarding LCS, and restriction of activities of daily living. Cardio-respiratory parameters were also measured. Statistical analysis included binary logistic and multiple linear regressions were performed with LCS as the dependent variable. Associated risk factors were identified using Structural Equation Modelling (SEM). Findings: Among 2198 participants, the prevalence of LCS at 12 weeks was 16.1%. Overall, eight LCS were identified and in descending order of prominence are: fatigue, pain, dyspnea, cough, anosmia, appetite loss, headache, and chest pain. COVID survivors experienced between 1 to 5 LCS with an overall duration period of 21.8 SD 5.2 weeks. SEM predicted the length of LCS to be related to younger age, female gender, rural residence, prior functional limitation and smoking. Interpretation: In this cohort of survivors, at 31 weeks post diagnosis, the prevalence of LCS was 16.1%. The risk factors identified for presence and longer length of LCS warrant further research and consideration to support public health initiatives. Funding: No funding Individual recovery from COVID-19 infection varies, and it is not fully understood why some people experience persistent symptoms over a longer time period than others. Post-acute COVID-19 syndrome 1 (PACS)and Post-COVID-19 syndrome 2 are terms used clinically to describe ongoing or new symptoms that occur after the fourth week of recovery from an acute infection, that cannot be explained by an alternative medical diagnosis. The experience of longer-term symptoms has prompted some patient groups to invent and use the term "Long COVID" 3 to describe their experience of ongoing symptoms, that persist beyond four weeks from suspected infection or positive diagnosis to over 12 weeks and longer. It is now understood that COVID-19 can impact on multiple organ systems 4 , which can lead to a diverse range of persistent symptoms including fatigue, breathlessness, cough, loss of taste and/or smell, myalgia, memory issues and gastrointestinal problems. [5] [6] An integrative post COVID symptom model was recently proposed for symptom classification after confirmed diagnosis of COVID-19 7 This model incorporates reference to the "relapsing remitting" 8 pattern of symptoms experienced by many survivors and has been adopted to assist in presentation of results. A large recent survey conducted over a four-week period in the UK found that 1.1 million people self-reported "long COVID" symptoms (LCS), which equates to 1.7% of the population. 9 The survey also identified that 18.1% of participants reported that their daily activities had been affected a lot by the illness, indicating that "Long COVID" has a detrimental impact on peoples' day to day lives, so should be taken seriously. 10 It is acknowledged that there is a need for further research into the prevalence and duration of LCS experienced by survivors 11 and potential associated risk factors so that overall clinical management can be improved 12 .This is especially pertinent in Low to Middle Income Countries 13 like Bangladesh, where the majority of the population live in rural districts 14 outside of the densely populated capital city, Dhaka. There are only two published studies so far in Bangladesh on persistent symptoms following COVID-19 infection. One survey of 1002 individuals reported that 20% had experienced persisting symptoms after COVID-19, with diarrhea (12.7%) being most common followed by fatigue (11.5%). 15 A second smaller study of 355 individuals found that 46% of patients recovering from COVID-19 reported LCS 16 with fatigue being the most common symptom reported. Therefore, it is critical to gain research knowledge on the prevalence of LCS and identify associated risk factors, as this study does, which will be of relevance to the global community. 4 The aim of this study was to identify the prevalence of LCS in Covid-19 survivors and explore any potential associations between reported symptoms and the independent variables measured. Cardio-respiratory parameters and functional restrictions were also measured to try to discern if there was an impact on the cardiac system and if functional daily activities were affected by LCS. This prospective study utilized an inception cohort of adult COVID-19 survivors recruited from a large population sample frame of 14392 COVID positive cases. These cases were identified from 24 testing facilities across Bangladesh between June and November 2020. All COVID-19 positive and negative diagnoses were performed using a RT-PCR test (Real time polymerase chain reaction test) 17 . Inclusion criteria were: age 18 years and over; people who reported persistent symptoms after positive diagnosis and people who reported difficulties in undertaking usual daily activities. Exclusion criteria were: individuals too sick to participate; those who declined consent and those we were unable to contact. The sample size calculation was performed using "EPI INFO" software version 7.4. Data was collected by eight trained data collectors from the Centre for the Rehabilitation of the Paralyzed (CRP). Data collectors were comprehensively trained by the study team regarding study aims, ethical considerations, questionnaires and clinical outcome measures. Screening for trial eligibility and consent for data collection was conducted using mobile telephones. Face to face data collection was undertaken via mutually convenient scheduled 5 appointments either in the respondent's house or workplace. All data collectors adhered scrupulously to the COVID-19 preventative precautions, use of personal protective equipment (PPE) and health regulations. Consent and questionnaire documents were provided as hard paper copies in Bengali for respondents to complete themselves. If there was a literacy issue then data collectors provided support with this to enable completion. Data was then collated anonymously from these documents and transferred into an Excel workbook for audit and analysis. A small-scale pilot study using 17 respondents was initially conducted to test applicability and feasibility of the questionnaire. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. (Tables 1 and 2 ). Relationships between a categorical independent variable (for example, LCS) and a parametric socio-demographic dependent variable were determined through independent t tests. In addition, relationships among two or more categorical . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint variables were explored using the chi-square test ( Table 2) . To ascertain which factors were potentially related to LCS, binary logistic regression was performed with the presence of LCS as the dependent variable (Table 3 ) and multiple linear regressions were performed with the duration of LCS as the dependent variable (Table 4) From 14392 estimated samples, 13222 respondents were called by telephone.62.79% (8303) COVID survivors reported complete recovery and 27.23% (3920) stated that they faced difficulties when undertaking daily activities. The study had a reasonably good response rate of 56.8%. This study found that 22.5% (495) of COVID survivors had PACS at 4 weeks post diagnosis and 16.1% (356) had LCS at 12 weeks post diagnosis ( Figure 1 ). The mean age of all ACS (n=2198) was 38.07 ± 11.4 years, survivors with PACS (n=495) 38.86±11.3 and those survivors with LCS (n=356) had mean age 38.42±11.3. The majority of the ACS were between 31 and 40 years of age 43.3% (718) and 30.4% (669) were aged [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] years. The male to female ratio of the respondents was 2.6:1. Respondents covered all eight . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. Table 1 . . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint According to WHO working group classification 24 , 63.2% (1390) of the ACS had mild COVID, 23.7% (520) had moderate COVID and .4% (8) had severe COVID-19. The ratio of the severity in ACS, PACS and LCS were mostly similar (Table 1) .93.9% (2063) respondents opted to follow the advice of the government telemedicine team by resting at home, undertaking isolation and using advised medication. 5.7% (126) needed supplementary oxygen either at home or hospital, .2% (5) were admitted to hospital and required noninvasive ventilation and .2% (4) were admitted to a dedicated COVID Intensive Care Unit (ICU) with or without mechanical ventilation. Further detail of the COVID related information of ACS, PACS and LCS are appended in Table 1 . The mean resting heart rate for participants with PACS and LCS was 82.5±6. 9 figure 5 shows, no notable changes of mean in LCS compared to all COVID survivors. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint Table 2 represents a segregated relationship of socio-demographic and health related factors with LCS in correlation model. Categorical age was associated with LCS (p<.05), whereas pain was associated separately with overall age of the population (p<.05). LCS were associated with gender (p<.01), marital status (p<.05), area of residence (p<.01), occupation (p<.001) and severity of COVID-19 (p<.001). Table 3 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint duration of LCS was positively associated (R 2 .041) with being female (β.12, p<.001), limited function (β.09, p<.001), smokers(β.08, p<.01), and people living in rural areas (β.06, p<.05). Interestingly, age has a reverse relationship with a longer duration of LCS (β -.05, p<.05). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint Significant relationship values with a minimum of 5% margin of error are bolded and marked as * p<·05, ** p<·01, *** p<·001 identifying risk factors associated with a longer time length of these symptoms. In this study, the most common symptom during the acute phase was fever, closely followed by fatigue and upper respiratory tract symptoms. This is consistent with literature that has reported similar symptoms. [25] [26] The study found eight LCS, with fatigue being the most common symptom closely followed by muscle pain and dyspnea. In another study 27 , after three to nine months, 14% of individuals had fatigue problems. Most available literature unanimously reports fatigue 1, 15, 16 as the most common LCS. After this, many studies reportbreathlessness 28,1,6 as the second most common LCS with other studies citing anosmia, cough and myalgia to also be common. 29 Augustin et al 30 , reported a study where nonhospitalized COVID-19 patients had more anosmia (12.4%) and ageusia (11.1%) than fatigue (9.7%) and shortness of breath (8.6%) over a four-to-seven-month recovery period. This study reported that the majority of respondents had mild to moderate COVID-19 and approximately 93% decided to stay at home to recover without hospital treatment.62% (308) of respondents with LCS reported mild disease, which would not require hospitalization. There is a paucity of literature in this area, which perhaps reflects the challenge of how to collect and gather data from people who do not perceive that they are sick enough to require hospital treatment and also considering that Bangladesh is an under-resourced country and the hospital system is private so usually hospital admission and treatment costs money. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint Figure 4 highlights the relapsing remitting nature of LCS reported over time between 13 to 31 weeks with maximum symptoms reported between 25 to 26 weeks, which is consistent with other research 1, 5, 7, 12, 17 . In figure 5 , it is apparent that there was little difference noted between the cardio-respiratory function variables measured for PACS and LCS survivors. In terms of functional limitations, it is clear from Figure 6 , that people with LCS had more functional limitations when compared with all ACS. Overall, this study found that age (< 30 years); rural geographic residence; housewife role or private sector occupation; one or more comorbidities; smoking; a longer acute COVID recovery period, a positive Rhesus factor in the blood group and prior functional limitations were all predictive risk factors for LCS. To our awareness, this is the first study to identify specific risk factors for Long COVID within the general population and whilst the specific context is Bangladesh, we think that these risk factors warrant further investigation in all global community populations. Previous studies on Long COVID in Bangladesh focused on urban areas and did not include rural regions, as this study did, which is now identified as a risk factor Whilst males (m) comprised the majority of respondents with LCS (69.0%), it was the females (f) who reported a greater proportion of LCS, (over all f = 25.2%, m=21.2%). This may be due to the overall higher incidence of COVID-19 diagnosed and reported by men in Bangladesh and the lack of sex disaggregated data in previous studies. The female sex was significantly associated with a longer duration of COVID symptoms. In addition, women reported slightly higher levels of fatigue, followed by pain, anosmia, and insomnia (f = 1.3%, m=0.3 %;). In contrast, men reported slightly higher levels of dyspnea, ageusia, cough and chest pain. A significant positive association was found between gender and functional limitations. Women and those with cardio-respiratory comorbidity were more likely to develop functional limitations during the Long COVID period. In contrast, men and those with mild COVID symptoms were inversely associated with functional limitations. The limitations of this study include that the sample was taken from twenty-four testing centres, and it is appreciated that people, who have attended these centres for diagnosis may not be truly representative of all communities within the Bangladeshi population. However, it will be possible for the team to contact and follow up on this cohort for longitudinal data in the future. In addition, the limited nature of resources meant that a proportion of potential . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint participants could not be contacted due to system and educational constraints and the researchers had limited access to the electronic database. The LCS in this study were described by the survivors and screened by the data collectors, who were medical students. A clinical screening by healthcare professionals might reveal more in-depth symptom responses. In this study, the prevalence of LCS was identified to be 22.5% at 4 weeks and 16.1% at 12 weeks post diagnosis. In addition, the study identified some key predictors for the presence of LCS, in terms of associated risk factors and also risk factors associated with a longer duration of Long COVID illness. Further research is needed to gain more insight into these identified risk factors and what can be done to support communities affected by it. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint call and written consent was obtained at interview. The principles of the Helsinki Declaration 19 were followed throughout the research to ensure confidentiality, ethics and privacy. We declare no competing interests. All data collected in this study is confidential to the study and will be shared anonymously or following ethical principle and made available to others according to the necessity of the study. Data will be available at a public repository. (https://www.kaggle.com/kmamranhossain/long-covid-bd). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21259626 doi: medRxiv preprint Post-acute COVID-19 syndrome COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline Why the Patient-Made Term 'Long Covid' is needed Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study A conceptual framework to accelerate the clinical impact of evolving research into long COVID 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Defining Post-COVID Symptoms (Post-Acute COVID An Integrative Classification How to define it and how to manage it. The BMJ Office for National Statistics. Prevalence of ongoing symptoms following Coronavirus (COVID-19) infection in the UK: 1 Scientists set out to connect the dots on long Covid Research priorities for Long Covid: refined through an international multi-stakeholder forum Management of post-acute covid-19 in primary care The occurrence of long COVID: a rapid review Bangladesh Population (Live) Accessed via Worldometer website Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh World Health Organization (WHO) Health Emergency Dashboard WMA Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19 Process of translation and adaptation of instruments. Online guidance. Website accessed Working Group on the Clinical Characterisation andManagement of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research Persistent symptoms 1.5 -6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study Landi F for the Gemelli Against COVID-19 Post-Acute Care Study Group Sequelae in Adults at 6 Months After COVID-19 infection Post discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation We thank all individuals who participated in this study and their families.